Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting

BACKGROUND: Magnetic resonance imaging (MRI) is the best biomarker of inflammatory disease activity in relapsing remitting Multiple Sclerosis (RRMS) so far but the association with disability is weak. Appearance of new MRI-lesions is used to evaluate response to immunotherapies in individual patient...

Descripción completa

Detalles Bibliográficos
Autores principales: von Gumberz, Johanna, Mahmoudi, Mina, Young, Kim, Schippling, Sven, Martin, Roland, Heesen, Christoph, Siemonsen, Susanne, Stellmann, Jan-Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2016
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036070/
https://www.ncbi.nlm.nih.gov/pubmed/27688965
http://dx.doi.org/10.7717/peerj.2442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036070/
https://www.ncbi.nlm.nih.gov/pubmed/27688965
http://dx.doi.org/10.7717/peerj.2442

Ejemplares similares